Aaron Paul Kithcart: Connecting Science and Collaboration in Nagasaki
Aaron Paul Kithcart, Senior Medical Director in Translational and Clinical Sciences of Hematology at Regeneron, shared a post on LinkedIn:
“This weekend, I was in Nagasaki for the Japan College of Cardiology meeting.
It was a productive trip and a great opportunity to connect in person with investigators and colleagues participating in our FXI studies in atrial fibrillation and peripheral artery disease.
Beyond the scientific discussions, I really enjoyed learning more about Nagasaki and its unique place in Japanese history.
For centuries, Nagasaki served as Japan’s sole trading port open to foreign countries, making it an important gateway for international exchange and the exchange of ideas.
It was a great visit all around, and I’m grateful to all of the investigators and colleagues who took the time to meet, share their insights, and advance our work together.
Looking forward to many more years of collaboration and continuing the important work we are doing together in thrombosis.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI